Role of limited sublobar resection for early-stage lung cancer: steady progress

Affiliations

Editorial

Hisao Asamura. J Clin Oncol. 2014.

. 2014 Aug 10;32(23):2403-4.

doi: 10.1200/JCO.2014.56.4203. Epub 2014 Jun 30.

No abstract available

Comment on

Recurrence and survival outcomes after anatomic segmentectomy versus lobectomy for clinical stage I non-small-cell lung cancer: a propensity-matched analysis.
Landreneau RJ, Normolle DP, Christie NA, Awais O, Wizorek JJ, Abbas G, Pennathur A, Shende M, Weksler B, Luketich JD, Schuchert MJ. Landreneau RJ, et al. J Clin Oncol. 2014 Aug 10;32(23):2449-55. doi: 10.1200/JCO.2013.50.8762. Epub 2014 Jun 30. J Clin Oncol. 2014. PMID: 24982447 Free PMC article.
Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancer.
Fernando HC, Landreneau RJ, Mandrekar SJ, Nichols FC, Hillman SL, Heron DE, Meyers BF, DiPetrillo TA, Jones DR, Starnes SL, Tan AD, Daly BD, Putnam JB Jr. Fernando HC, et al. J Clin Oncol. 2014 Aug 10;32(23):2456-62. doi: 10.1200/JCO.2013.53.4115. Epub 2014 Jun 30. J Clin Oncol. 2014. PMID: 24982457 Free PMC article. Clinical Trial.